Early Feasibility Testing and Engineering Development of the Transapical Approach for the HeartWare MVAD Ventricular Assist System
- 1 March 2014
- journal article
- adult circulatory-support
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 60 (2) , 170-177
Abstract
Implantation of ventricular assist devices (VADs) for the treatment of end-stage heart failure (HF) falls decidedly short of clinical demand, which exceeds 100,000 HF patients per year. Ventricular assist device implantation often requires major surgical intervention with associated risk of adverse events and long recovery periods. To address these limitations, HeartWare, Inc. has developed a platform of miniature ventricular devices with progressively reduced surgical invasiveness and innovative patient peripherals. One surgical implant concept is a transapical version of the miniaturized left ventricular assist device (MVAD). The HeartWare MVAD Pump is a small, continuous-flow, full-support device that has a displacement volume of 22 ml. A new cannula configuration has been developed for transapical implantation, where the outflow cannula is positioned across the aortic valve. The two primary objectives for this feasibility study were to evaluate anatomic fit and surgical approach and efficacy of the transapical MVAD configuration. Anatomic fit and surgical approach were demonstrated using human cadavers (n = 4). Efficacy was demonstrated in acute (n = 2) and chronic (n = 1) bovine model experiments and assessed by improvements in hemodynamics, biocompatibility, flow dynamics, and histopathology. Potential advantages of the MVAD Pump include flow support in the same direction as the native ventricle, elimination of cardiopulmonary bypass, and minimally invasive implantation.Keywords
This publication has 18 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Executive Summary: Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation, 2012
- Unforeseen Consequences of Therapy With Continuous-Flow PumpsCirculation: Heart Failure, 2010
- Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implantsThe Journal of Heart and Lung Transplantation, 2010
- Heart Disease and Stroke Statistics—2008 UpdateCirculation, 2008
- Development of “Plug and Play” TransApical to Aorta VADASAIO Journal, 2007
- Ascending Aorta Outflow Graft Location and Pulsatile Ventricular Assist Provide Optimal Hemodynamic Support in an Adult Mock CirculationArtificial Organs, 2005
- An Intraventricular Axial Flow Blood Pump Integrated With a Bearing Purge SystemASAIO Journal, 1995
- Catheter Replacement of the Needle in Percutaneous Arteriography: A new techniqueActa Radiologica, 1953